Eisai Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
599,490
548,465
547,922
539,097
600,054
642,834
Cost of Goods Sold (COGS) incl. D&A
208,965
207,885
208,083
208,006
213,455
196,398
Gross Income
390,525
340,580
339,839
331,091
386,599
446,436
SG&A Expense
325,338
312,098
296,722
279,886
311,004
346,515
EBIT
-
27,778
42,779
51,205
75,595
99,921
Unusual Expense
-
65
4,778
598
286
14,670
Non Operating Income/Expense
2,576
1,628
14,663
8,696
2,522
1,556
Interest Expense
5,707
4,745
3,457
2,775
2,826
1,456
Pretax Income
62,298
25,875
50,473
57,668
76,803
89,454
Income Tax
23,797
17,579
4,571
15,422
22,378
22,971
Consolidated Net Income
38,501
43,454
55,044
42,246
54,424
66,484
Net Income
38,251
43,254
54,933
39,359
51,845
63,386
Net Income After Extraordinaries
38,251
43,254
54,933
39,359
51,845
63,386
Net Income Available to Common
38,251
43,254
54,933
39,358
51,845
63,386
EPS (Basic)
134.13
151.57
192.23
137.62
181.18
221.34
Basic Shares Outstanding
285
285
286
286
286
286
EPS (Diluted)
134.01
151.37
191.76
137.41
180.97
221.12
Diluted Shares Outstanding
285
286
286
286
286
287
EBITDA
104,302
66,718
76,843
77,689
101,778
126,762
Other Operating Expense
814
704
338
-
-
-
Non-Operating Interest Income
963
1,204
1,196
1,084
1,752
4,163
Minority Interest Expense
250
200
111
2,887
2,579
3,098
Equity in Affiliates (Pretax)
93
75
70
55
46
59

About Eisai Co.

View Profile
Address
4-6-10 Koishikawa
Tokyo Tokyo 112
Japan
Employees -
Website http://www.eisai.co.jp
Updated 07/08/2019
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs.